BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32129525)

  • 1. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
    Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
    Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.
    Pan J; Zang Y
    Dig Dis Sci; 2022 Jul; 67(7):2936-2947. PubMed ID: 34313922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
    Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
    Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
    [No Abstract]   [Full Text] [Related]  

  • 4. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.
    Li MM; Dong CX; Sun B; Lei HZ; Wang YL; Gong YB; Sun LL; Sun ZW
    Life Sci; 2019 Dec; 239():116946. PubMed ID: 31610202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
    Wu H; Wang G; Wang Z; An S; Ye P; Luo S
    FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells.
    Che G; Gao H; Tian J; Hu Q; Xie H; Zhang Y
    Pediatr Dev Pathol; 2020; 23(2):144-151. PubMed ID: 31498707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
    Chen ZH; Cui MY; Zhang HM
    Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1.
    Guo ZT; Yu Q; Miao C; Ge W; Li P
    Mol Cell Biol; 2022 Aug; 42(8):e0039721. PubMed ID: 35862727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LINC01339 Hinders the Development of Wilms' Tumor via MiR-135b-3p/ADH1C Axis.
    Yu Y; Liu Y
    Horm Metab Res; 2024 Mar; 56(3):244-254. PubMed ID: 37890508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
    Zhu KR; Sun QF; Zhang YQ
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
    Shen J; Shu Q
    Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MIAT acts as an oncogene in Wilms' tumor through regulation of DGCR8.
    Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10257-10263. PubMed ID: 31841180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour.
    Wang H; Zhang Y
    Arch Esp Urol; 2024 Mar; 77(2):135-141. PubMed ID: 38583005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.
    Wang HF; Zhang YY; Zhuang HW; Xu M
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3360-3369. PubMed ID: 28829507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
    Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
    Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing long non-coding RNA SNHG6 restrains proliferation, migration and invasion of Wilms' tumour cell lines by regulating miR-15a.
    Su L; Wu A; Zhang W; Kong X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2670-2677. PubMed ID: 31257923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.